Login / Signup

Epigenetic Modification 6-Methyladenosine Can Impact the Potency and Specificity of siRNA.

Anna M RydzikDirk GottschlingEric SimonWioletta Skronska-WasekJörg F RippmannDoris Riether
Published in: Chembiochem : a European journal of chemical biology (2020)
The introduction of N6-methyladenosine (m6 A) into siRNA targeting Factor VII impacts its potency in cells and has a significant influence on the selectivity of siRNA, including reduced off-targeting. These effects are dependent on the position of m6 A in the siRNA duplex, with some of the sequences identified as more potent and/or selective than their non-methylated counterpart. These findings broaden the repertoire of available chemical modifications for siRNA therapeutics and imply potential regulatory role of N6-methyladenosine in the RNAi pathways.
Keyphrases
  • cancer therapy
  • drug delivery
  • hyaluronic acid
  • induced apoptosis
  • dna methylation
  • gene expression
  • small molecule
  • oxidative stress
  • climate change
  • risk assessment
  • signaling pathway